Data Foundry

Medical device recalls 2016

BD-Retic-Count Reticulocyte Reagent System — Class III medical device recall Z-1390-2016

Terminated recall by Becton, Dickinson and Company, BD Biosciences, reported 2016-04-20, distributed in CA, CT, DC, FL, IN, MA, MN, NY…. The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage condition

Recall numberZ-1390-2016
Product typeMedical device
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBecton, Dickinson and Company, BD Biosciences, San Jose, CA, United States
Recall initiated2016-03-18
Classified2016-04-14
Reported by FDA2016-04-20
Terminated2016-12-02
DistributedCA, CT, DC, FL, IN, MA, MN, NY, UT, VA
Countries outside the USBE, BR, CA, CN, IN, JP, KR, SG, TW
Quantity205
Reason classeslabeling
Lot numbers5175559
Expiration dates2016-05-31

Product

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Reason for recall

The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1390-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.